BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9186171)

  • 1. Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment.
    Ramachandran S; Giles PD; Hartland A
    BMJ; 1997 May; 314(7094):1593. PubMed ID: 9186171
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe rhabdomyolysis during a hypersensitivity reaction to abacavir in a patient treated with ciprofibrate.
    Fontaine C; Guiard-Schmid JB; Slama L; Essid A; Lukiana T; Rondeau E; Pialoux G
    AIDS; 2005 Nov; 19(16):1927-8. PubMed ID: 16227807
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute rhabdomyolysis during treatment with ciprofibrate].
    Delangre T; Vernier L; Moore N; Mihout B
    Presse Med; 1990 Nov; 19(39):1811-2. PubMed ID: 2148009
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rhabdomyolysis and unexplained malaise. Role of combination of ciprofibrate and norfloxacin].
    Blain H; Klein M; Weryha G; Tréchot P; Hanesse B; Leclère J
    Rev Med Interne; 1996; 17(10):859-60. PubMed ID: 8976986
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ciprofibrate-induced acute cholestatic hepatitis].
    Pflumio F; Andrès E; Ubrich M; Geisler F; Imbs JL; Di Liberatore M
    Ann Endocrinol (Paris); 2003 Jun; 64(3):232-3. PubMed ID: 12910067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute severe fibrosing hepatitis associated with ciprofibrate treatment].
    Dumortier J; Slim R; Chevallier M; Boillot O; Thaunat JL; Vaillant E; Vial T; Bellemin B; Paliard P; Scoazec JY
    Gastroenterol Clin Biol; 1999 Dec; 23(12):1399-400. PubMed ID: 10642628
    [No Abstract]   [Full Text] [Related]  

  • 7. Ciprofibrate and lipid profile.
    McLeod AJ; Warren RJ; Armitage M
    Lancet; 1994 Oct; 344(8927):955. PubMed ID: 7934365
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of rhabdomyolysis and thromboembolic event secondary to fibrate monotherapy.
    Yildiz A; Gucuk E; Cay S
    Acta Cardiol; 2008 Aug; 63(4):515-7. PubMed ID: 18795591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrate-induced increase in blood urea and creatinine.
    Lipscombe J; Bargman JM
    Nephrol Dial Transplant; 2001 Jul; 16(7):1515. PubMed ID: 11427661
    [No Abstract]   [Full Text] [Related]  

  • 10. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Mikhailidis DP; Jagroon IA
    Metabolism; 2001 Nov; 50(11):1385-6. PubMed ID: 11715936
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytolytic hepatic damage caused by ciprofibrate].
    Perault MC; Fievre JL; Dejean C; Martin A; Vandel B
    Gastroenterol Clin Biol; 1992; 16(6-7):609. PubMed ID: 1526424
    [No Abstract]   [Full Text] [Related]  

  • 12. Rhabdomyolysis and acute renal failure associated with gemfibrozil therapy.
    Górriz JL; Sancho A; Lopez-Martin JM; Alcoy E; Catalán C; Pallardó LM
    Nephron; 1996; 74(2):437-8. PubMed ID: 8893176
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrates and renal function.
    Gajdos M; Dzúrik R
    Clin Nephrol; 2003 Jul; 60(1):65-6. PubMed ID: 12872864
    [No Abstract]   [Full Text] [Related]  

  • 14. Ciprofibrate and lipid profile.
    Chandler HA; Batchelor AJ
    Lancet; 1994 Jul; 344(8915):128-9. PubMed ID: 7912363
    [No Abstract]   [Full Text] [Related]  

  • 15. Ciprofibrate versus gemfibrozil in the treatment of primary hyperlipidaemia.
    Knipscheer HC; de Valois JC; van den Ende B; Wouter ten Cate J; Kastelein JJ
    Atherosclerosis; 1996 Jul; 124 Suppl():S75-81. PubMed ID: 8831919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myositis, hypothyroidism and fibrates].
    Wechsler B; Doumith R; Weil M
    Rev Med Interne; 1991; 12(6):475. PubMed ID: 1792441
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrate monotherapy and profound hypoalphalipoproteinaemia.
    Olukoga AO; Crowley VE; Stewart MF; Weinkove O
    Postgrad Med J; 1996 Mar; 72(845):189. PubMed ID: 8731722
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute rhabdomyolysis associated with digestive disorders during a voluntary overdose of ciprofibrate].
    Giraud O; Chanu B; Farge D; Parrot F; Brestescher C; Rouffy J
    Gastroenterol Clin Biol; 1995 Feb; 19(2):231-2. PubMed ID: 7750722
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug-induced myopathies].
    Ando H; Fujimura A
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():390-3. PubMed ID: 18074569
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrate treatment can increase serum creatinine levels.
    Tsimihodimos V; Kakafika A; Elisaf M
    Nephrol Dial Transplant; 2001 Jun; 16(6):1301. PubMed ID: 11390746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.